IP Library Granted Patent US 8,957,115
Granted Patent B2
US 8,957,115 · App. 13/903,043 · Granted Feb 17, 2015

Pheromone compositions and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,957,115
App. No.
13/903,043
Granted
Feb 17, 2015
Kind
B2
Abstract

Pheromone compositions based on a combination of squalene, linoleic acid and 1-docosanol are described. The compositions are useful for behavior modification in mammals that exhibit undesirable or harmful stress-related behaviors.

Claims (14)

1. A pheromone composition for modifying behavior of an animal consisting of 30%-80% by weight of squalene, 10-75% by weight of linoleic acid, 1%-10% by weight of 1-docosanol, 0.1%-10% by weight of cholesterol, 0.01% by weight of butylated hydroxytoluene (BHT), and optionally, 0.1%-10% by weight of a mixture of lauric acid, myristic acid and n-pentadecanoic acid, and wherein the total weight percent of all components present in the composition does not exceed 100%.

2. The pheromone composition of claim 1 consisting of 30%-35% by weight of squalene, 55-65% by weight of linoleic acid, 2%-5% by weight of 1-docosanol, 1%-5% by weight of cholesterol, 0.01% by weight of BHT, and optionally, 2%-10% by weight of a mixture of lauric acid, myristic acid and n-pentadecanoic acid.

3. The pheromone composition of claim 1 consisting of 65%-70% by weight of squalene, 18%-21% by weight of linoleic acid, and 2%-5% by weight of 1-docosanol, 1%-5% by weight of cholesterol, and 0.01% by weight of BHT.

4. A pheromone solution for modifying behavior of an animal consisting of:

a. about 0.5%-40% by volume of a pheromone composition consisting of 30%-35% by weight of squalene, 55-65% by weight of linoleic acid, 2%-5% by weight of 1-docosanol, 1%-5% by weight of cholesterol, 0.01% by weight of BHT, and optionally, 2%-10% by weight of a mixture of lauric acid, myristic acid and n-pentadecanoic acid; and

b. about 70%-90% by volume of an organic solvent.

5. The pheromone solution of claim 4 , wherein the solvent is selected from the group consisting of ethanol, butanol, propanol, phenyl ethyl alcohol, ethylene glycol, propylene glycol, dipropylene glycol methyl ether, dipropylene glycol monoethyl ether, ether, isopropyl palmitate, chloroform, benzene, carbon disulfide, silicone fluid, oils including non-volatile and volatile oils, and combinations thereof.

6. The pheromone solution of claim 4 wherein the composition contributes about 0.5%-15% by volume to the pheromone solution.

7. A pheromone solution for modifying behavior of an animal consisting of:

a. about 10%-30% by volume of a pheromone composition consisting of 65%-70% by weight of squalene, 15%-25% by weight of linoleic acid, 2%-5% by weight of 1-docosanol, 1% by weight of cholesterol, 0.01% by weight of BHT, and optionally, 6%-9% by weight of a mixture of lauric acid, myristic acid and n-pentadecanoic acid, ; and

b. about 70%-90% by volume of an organic solvent.

8. A method of modifying stress-related behavior in a mammal comprising administering to the mammal a therapeutically effective amount of the pheromone composition of claim 1 .

9. A method of modifying stress-related behavior in a mammal comprising administering to the mammal a therapeutically effective amount of the pheromone solution of claim 4 .

10. A method of modifying stress-related behavior in a mammal comprising administering to the mammal a therapeutically effective amount of the pheromone solution of claim 7 .

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: JEFFERIES FINANCE LLC
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069052/0290 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: KEYBANK NATIONAL ASSOCIATION
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069269/0614 →
FIRST LIEN PATENT SECURITY AGREEMENT (TL) Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069272/0659 →
ABL PATENT SECURITY AGREEMENT Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: KEYBANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 069272/0670 →
SECURITY INTEREST Recorded Apr 14, 2021
From: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT'S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
To: JEFFERIES FINANCE LLC
Reel/Frame 055915/0408 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT R/F 049711/0975 Recorded Apr 14, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 055923/0978 →
ENTITY CONVERSION Recorded Oct 18, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: SERGEANT'S PET CARE PRODUCTS, LLC
Reel/Frame 050767/0170 →
SECURITY INTEREST Recorded Jul 10, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049711/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: RIOS, LUIS; NOUVEL, LARRY
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 030502/0608 →